Suchergebnisse - "Geng, Ziqian"

PubPharm (13)

1

Upadacitinib Induction and Maintenance Therapy for Crohn's Disease

enthalten in: The New England journal of medicine | 2023

von Loftus, E. | Panés, J. | Lacerda, A. | +16

CommentIn: Ann Intern Med. 2023 Sep;176(9):JC103. - PMID 37665995

2

Efficacy and Safety of Risankizumab for the Treatment of Hidradenitis Suppurativa : A Phase 2, Randomized, Placebo-Controlled Trial

enthalten in: Dermatology and therapy | 2023

von Kimball, A. | Prens, E. | Passeron, T. | +8

3

Efficacy, safety, usability, and acceptability of risankizumab 150 mg formulation administered by prefilled syringe or by an autoinjector for moderate to severe plaque psoriasis

enthalten in: The Journal of dermatological treatment | 2022

von Blauvelt, A. | Gordon, K. | Lee, P. | +8

4

Deep historical borrowing framework to prospectively and simultaneously synthesize control information in confirmatory clinical trials with multiple endpoints

enthalten in: Journal of biopharmaceutical statistics | 2022

von Zhan, T. | Zhou, Y. | Geng, Z. | +5

5

Efficacy and Safety of Adalimumab in Conjunction With Surgery in Moderate to Severe Hidradenitis Suppurativa : The SHARPS Randomized Clinical Trial

enthalten in: JAMA surgery | 2021

von Bechara, F. | Podda, M. | Prens, E. | +9

CommentIn: JAMA Surg. 2022 Jun 1;157(6):552-553. - PMID 35262636

6

A practical response adaptive block randomization (RABR) design with analytic type I error protection

enthalten in: Statistics in medicine | 2021

von Zhan, T. | Cui, L. | Geng, Z. | +3

7

An automation-based adaptive seamless design for dose selection and confirmation with improved power and efficiency

enthalten in: Statistical methods in medical research | 2021

von Cui, L. | Zhan, T. | Zhang, L. | +3

8

Effect of Risankizumab on Patient-Reported Outcomes in Moderate to Severe Psoriasis : The UltIMMa-1 and UltIMMa-2 Randomized Clinical Trials

enthalten in: JAMA dermatology | 2020

von Augustin, M. | Lambert, J. | Zema, C. | +8

9

Efficacy and Safety of Continuous Risankizumab Therapy vs Treatment Withdrawal in Patients With Moderate to Severe Plaque Psoriasis : A Phase 3 Randomized Clinical Trial

enthalten in: JAMA dermatology | 2020

von Blauvelt, A. | Leonardi, C. | Gooderham, M. | +10

10

Achieving Hidradenitis Suppurativa Response Score is Associated with Significant Improvement in Clinical and Patient-reported Outcomes : Post Hoc Analysis of Pooled Data From PIONEER I and II

enthalten in: Acta dermato-venereologica | 2018

von Kimball, A. | Tzellos, T. | Calimlim, B. | +3